VNDA
Vanda Pharmaceuticals Inc.- Sector
- Biotechnology
- Last price
- $6.24
- As of
Active signals for VNDA
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 16.8% — EPS $-0.82 vs $-0.7018 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 26.4% — EPS $-0.46 vs $-0.3638 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 66.0% — EPS $-0.46 vs $-1.3515 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 17.8% — EPS $-0.38 vs $-0.4624 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 17.8% — EPS $-0.38 vs $-0.4624 estimate
Top institutional holders of VNDA (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $29.8M | 0.05% | -2.8% |
| RENAISSANCE TECHNOLOGIES LLC | $26M | 0.04% | +11.2% |
| RENAISSANCE TECHNOLOGIES LLC | $17.3M | 0.02% | , |
| MILLENNIUM MANAGEMENT LLC | $16.2M | 0.01% | , |
| MILLENNIUM MANAGEMENT LLC | $14.8M | 0.01% | -48.4% |
| MILLENNIUM MANAGEMENT LLC | $13M | 0.01% | +12.0% |
| TWO SIGMA INVESTMENTS, LP | $9.7M | 0.01% | +42.8% |
| TWO SIGMA INVESTMENTS, LP | $8.6M | 0.01% | +47.8% |
| TWO SIGMA INVESTMENTS, LP | $3.3M | 0.00% | , |
| Point72 Asset Management, L.P. | $1.1M | 0.00% | +162.9% |
| Point72 Asset Management, L.P. | $542K | 0.00% | , |
| D. E. Shaw & Co., Inc. | $367K | 0.00% | , |
| CITADEL ADVISORS LLC | $177K | 0.00% | -22.4% |
| D. E. Shaw & Co., Inc. | $164K | 0.00% | -74.7% |
| CITADEL ADVISORS LLC | $129K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, VNDA
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more VNDA signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track VNDA in your watchlist and get notified the moment a new signal fires.
Track VNDA on Kresmion →